Literature DB >> 19607810

Peritoneal injection of fucoidan suppresses the increase of plasma IgE induced by OVA-sensitization.

Yuhki Yanase1, Takaaki Hiragun, Kazue Uchida, Kaori Ishii, Souichi Oomizu, Hidenori Suzuki, Shoji Mihara, Kazumasa Iwamoto, Hiroaki Matsuo, Nobukazu Onishi, Yoshikazu Kameyoshi, Michihiro Hide.   

Abstract

We previously reported that fucoidan, a dietary fiber purified from seaweed, inhibited IgE production by B cells in vitro. In this study, we examined the effect of fucoidan on IgE production in vivo. The OVA-induced increase of plasma IgE was significantly suppressed when fucoidan was intraperitoneally, but not orally, administered prior to the first immunization with OVA. The production of IL-4 and IFN-gamma in response to OVA in spleen cells isolated from OVA-sensitized mice treated with fucoidan in vivo was lower than that from mice treated without fucoidan. Moreover, the flow cytometric analysis and ELISpot assay revealed that the administration of fucoidan suppressed a number of IgE-expressing and IgE-secreting B cells, respectively. These results indicate that fucoidan inhibits the increase of plasma IgE through the suppression of IgE-producing B cell population, and the effect of fucoidan in vivo is crucially dependent on the route and timing of its administration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19607810     DOI: 10.1016/j.bbrc.2009.07.031

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Therapies from fucoidan; multifunctional marine polymers.

Authors:  Janet Helen Fitton
Journal:  Mar Drugs       Date:  2011-09-30       Impact factor: 6.085

2.  F-fucoidan from Saccharina japonica is a novel inducer of galectin-9 and exhibits anti-allergic activity.

Authors:  Yuka Tanino; Takashi Hashimoto; Takao Ojima; Masashi Mizuno
Journal:  J Clin Biochem Nutr       Date:  2016-05-21       Impact factor: 3.114

3.  Oral Administration of Fucoidan Can Exert Anti-Allergic Activity after Allergen Sensitization by Enhancement of Galectin-9 Secretion in Blood.

Authors:  Masashi Mizuno; Kana Sakaguchi; Iwao Sakane
Journal:  Biomolecules       Date:  2020-02-09

Review 4.  Fucoidan as a marine anticancer agent in preclinical development.

Authors:  Jong-Young Kwak
Journal:  Mar Drugs       Date:  2014-01-28       Impact factor: 5.118

5.  The Oligo Fucoidan Inhibits Platelet-Derived Growth Factor-Stimulated Proliferation of Airway Smooth Muscle Cells.

Authors:  Chao-Huei Yang; Chiung-Fang Tsao; Wang-Sheng Ko; Ya-Ling Chiou
Journal:  Mar Drugs       Date:  2016-01-09       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.